• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On August 19th, China Resources Beer (00291.HK) announced in Hong Kong that its unaudited consolidated revenue for the first half of 2026 was RMB24.24 billion, an increase of 1.2% year-on-year; unaudited profit before interest and tax was RMB6.881 billion; and profit attributable to shareholders was RMB5.169 billion, compared to RMB5.789 billion in the same period last year. Net cash inflow from operating activities reached RMB6.729 billion, an increase of 5.6% year-on-year. The Board of Directors declared an interim dividend of RMB0.446 per share, representing a payout ratio of 28%, an increase of 2 percentage points year-on-year.On August 19th, Hong Kong Exchanges and Clearing Limited (00388.HK) announced in Hong Kong that its revenue and other income and profit for the first half of 2026 reached a record high for any half-year. Revenue and other income for the first half of 2026 was HK$16.702 billion, an increase of 19% compared to the first half of 2025. EBITDA margin was 81%, an increase of 2 percentage points compared to the first half of 2025. Profit attributable to shareholders was HK$10.568 billion, an increase of 24% compared to the first half of 2025.August 19th - According to the Financial Times, sources familiar with the matter said that Iran is considering including military targets in Europe in its strike range should Trump escalate the war. The sources indicated that the Iranian military has assessed the possibility of striking US military assets in Bulgaria and other southeastern European countries. The Iranian military has also assessed the option of severing undersea fiber optic cables in the Strait of Hormuz in the event of an escalation.On August 19th, the National Healthcare Security Administration interpreted the "15th Five-Year Plan for Universal Medical Security." The plan proposes to steadily advance the national centralized procurement of medicines and high-value medical consumables, while guiding local governments to establish procurement alliances with "one province leading and nationwide participation." It aims to continuously deepen cooperation in areas such as traditional Chinese medicine, biopharmaceuticals, and medical consumables, gradually including medicines and medical consumables with high clinical usage and inflated prices into the procurement scope to reduce the financial burden on the public. In accordance with the requirements of the Party Central Committee and the State Council, the plan adheres to the principles of "stabilizing clinical use, ensuring quality, combating involution, and preventing bid-rigging," optimizing and improving procurement rules, further enhancing the matching degree between centralized procurement products and clinical needs, colluding with drug regulatory authorities to ensure the quality of selected products, guiding fair and rational competition in the industry, and resolutely cracking down on bid-rigging and collusion in the pharmaceutical centralized procurement field.On August 19th, the National Healthcare Security Administration interpreted the "15th Five-Year Plan for Universal Medical Security." The plan emphasizes vigorously promoting the development of commercial medical insurance. It actively supports and guides the complementary and differentiated development of commercial medical insurance with basic medical insurance, focusing on the diverse needs of the public. It supports commercial insurance companies in enriching their product offerings, with a focus on developing commercial insurance products that primarily cover areas outside the basic medical insurance catalog, offer high levels of coverage, and support pharmaceutical innovation. The aim is to meet the unmet needs of the public beyond basic medical insurance and promote the better supplementary role of commercial medical insurance in the multi-tiered medical security system.

AUD/JPY Exceeds 90.30 As RBA Considers Option To Raise Rates Prior To Pause

Daniel Rogers

Apr 18, 2023 14:02

AUD:JPY.png 

 

Following the release of the minutes from the Reserve Bank of Australia (RBA), the AUD/JPY pair surged above the 90.30-point critical resistance level. According to the RBA minutes, policymakers actively considered the decision to raise rates further. However, the decision to maintain the status quo was made after the collection of additional data.

 

Citing the resilience of Australia's financial system, RBA policymakers believed that the Board's future cash rate decisions would depend on the global economy, household spending trends, inflation projections, and employment forecasts.

 

Continue to monitor China's Gross Domestic Product (GDP) statistics. Compared to its stagnant performance in the final quarter of CY2022, the Chinese economy is estimated to have grown by 2.2%. Compared to the previous annual growth rate of 2.9%, the current annual growth rate for the economy is 4.0%. Australia is China's greatest trading partner, and stronger Chinese GDP data would strengthen the Australian Dollar.

 

The announcement of the People's Bank of China (PBOC) interest rate decision later this week will be crucial. Last week, the People's Bank of China pledged to provide additional monetary support to spur retail demand. Despite the reopening of China's economy following a period of economic restraint, the country's inflation rate has been consistently declining over the past few months.

 

According to Jiji news and Reuters, the Bank of Japan is reportedly considering a projection for consumer price growth between 1.6% and 1.9% for the 2025 fiscal year, a move seen as preventing market participants from betting on the central bank's departure from stimulus. This has also delayed the possibility of a shift away from an expansionary monetary policy, which cannot be considered until the Japanese inflation rate persists above 2%.